SCHEMBL1355100

SCHEMBL1355100

Cc1nc2c(C=O)ccc(Br)c2o1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK4 O00444 1/20 0.37
AURKA O14965 1/20 0.37
DAPK3 O43293 1/20 0.37
CDK1 P06493 1/20 0.37
PIM1 P11309 1/20 0.37
CDK2 P24941 1/20 0.37
SYK P43405 1/20 0.37
CLK2 P49760 1/20 0.37
GSK3A P49840 1/20 0.37
GSK3B P49841 1/20 0.37
CSNK2A1 P68400 1/20 0.37
PRKAA1 Q13131 1/20 0.37
CAMK2B Q13554 1/20 0.37
CAMK2G Q13555 1/20 0.37
CAMK2D Q13557 1/20 0.37
DYRK1A Q13627 1/20 0.37
TAOK1 Q7L7X3 1/20 0.37
PIM3 Q86V86 1/20 0.37
AURKB Q96GD4 1/20 0.37
HIPK2 Q9H2X6 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1355101 0.80 HPGD (0.33) PLK4AURKADAPK3CDK1PIM1
SCHEMBL1355102 0.80 HPGD (0.33) PLK4AURKADAPK3CDK1PIM1
SCHEMBL22439400 0.74 NQO2 (0.42) PLK4AURKADAPK3CDK1PIM1
SCHEMBL3188752 0.74 ELANE (0.44) PLK4AURKADAPK3CDK1PIM1
SCHEMBL15071013 0.73 RXFP1 (0.40) PLK4AURKADAPK3CDK1PIM1
SCHEMBL25104279 0.73 EGFR (0.33) ALDH1A1
SCHEMBL22439098 0.71 NQO2 (0.49) PLK4AURKADAPK3CDK1PIM1
SCHEMBL21979027 0.71 PLK4 (0.35) PLK4AURKADAPK3CDK1PIM1
SCHEMBL31682519 0.71 PLK4 (0.38) PLK4AURKADAPK3CDK1PIM1
SCHEMBL1352904 0.70 PLK4 (0.34) PLK4AURKADAPK3CDK1PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11447471-B2 α,β-unsaturated amide compound KYOWA KIRIN CO., LTD. (JP) 2022-09-20 US disclosed
US-20210155612-A1 Alpha,Beta-UNSATURATED AMIDE COMPOUND KYOWA KIRIN CO., LTD. (JP) 2021-05-27 US disclosed
EP-3712129-A1 ALPHA, BETA-UNSATURATED AMIDE COMPOUND Kyowa Kirin Co., Ltd. (JP) 2020-09-23 EP disclosed
US-9216973-B2 Insecticidal compounds SYNGENTA PARTICIPATIONS AG (CH) 2015-12-22 US disclosed
US-9216973-B2 Insecticidal compounds SYNGENTA PARTICIPATIONS AG (CH) 2015-12-22 US disclosed
US-9216973-B2 Insecticidal compounds SYNGENTA PARTICIPATIONS AG (CH) 2015-12-22 US disclosed
US-8859592-B2 Insecticidal compounds SYNGENTA CORP PROTECTION LLC (US) 2014-10-14 US disclosed
US-8859592-B2 Insecticidal compounds SYNGENTA CORP PROTECTION LLC (US) 2014-10-14 US disclosed
US-8859592-B2 Insecticidal compounds SYNGENTA CORP PROTECTION LLC (US) 2014-10-14 US disclosed
US-20130245072-A1 INSECTICIDAL COMPOUNDS SYNGENTA CORP PROTECTION LLC (US) 2013-09-19 US disclosed
US-20110288089-A1 INSECTICIDAL COMPOUNDS SYNGENTA CROP PROTECTION LLC (US) 2011-11-24 US disclosed
US-20110269804-A1 INSECTICIDAL COMPOUNDS SYNGENTA CROP PROTECTION LLC (US) 2011-11-03 US disclosed
US-20110269804-A1 INSECTICIDAL COMPOUNDS SYNGENTA CROP PROTECTION LLC (US) 2011-11-03 US disclosed
US-20110269804-A1 INSECTICIDAL COMPOUNDS SYNGENTA CROP PROTECTION LLC (US) 2011-11-03 US disclosed
EP-2379541-A2 INSECTICIDAL COMPOUNDS Syngenta Participations AG (CH) 2011-10-26 EP disclosed
EP-2331536-A1 INSECTICIDAL COMPOUNDS Syngenta Participations AG (CH) 2011-06-15 EP disclosed
WO-2010084067-A2 INSECTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2010-07-29 WO disclosed
WO-2010084067-A2 INSECTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2010-07-29 WO disclosed
WO-2010020522-A1 INSECTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2010-02-25 WO disclosed
WO-2010020522-A1 INSECTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2010-02-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210155612-A1 Alpha,Beta-UNSATURATED AMIDE COMPOUND NR1H2, NR1H3, RXRA PLK4 3151/4885AURKA 2190/4885DAPK3 3039/4885
US-20110288089-A1 INSECTICIDAL COMPOUNDS ACHE, CHRM1, CHRM2 PLK4 4471/4885AURKA 1349/4885DAPK3 3965/4885
US-11447471-B2 α,β-unsaturated amide compound NR1H2, RXRA, RXRB PLK4 3311/4885AURKA 1926/4885DAPK3 2882/4885
US-20130245072-A1 INSECTICIDAL COMPOUNDS ACHE, CHRM1, CHRM2 PLK4 4471/4885AURKA 1349/4885DAPK3 3965/4885
US-20110269804-A1 INSECTICIDAL COMPOUNDS CHRM1, CHRM2, C1R PLK4 4823/4885AURKA 1951/4885DAPK3 4555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.